Adaptive Biotechnologies

We will be at #ASH21. View our abstracts, schedule, and more: rebrand.ly/os00evu. @clonoSEQ is FDA-cleared to assess MRD in patients with CLL, MM, or B-ALL. For important info. incl. sample types & test limitations: rb.gy/8tju9y #AdaptiveAimsHigher

We are proud of the work done by our partners at @Survivor_Corps to raise the voices of patients. Check out this important review: rebrand.ly/acc31f Cc: @dianaberrent @NickGuthe @hmkyale @CesarCaraballoC @DaisySMassey @spin313 @limitlessliza.

Data from 30+ abstracts exhibiting the utility of NGS-based MRD testing will be shared at #ASH2021. 🔗 rebrand.ly/zdt4kkp@clonoSEQ is FDA-cleared to assess MRD in patients with CLL, MM, or B-ALL. For imp. info, incl. sample types & test limitations rb.gy/8tju9y

test Twitter Media - Data from 30+ abstracts exhibiting the utility of NGS-based MRD testing will be shared at #ASH2021. 🔗 https://t.co/EsfALhyY3M‌

@clonoSEQ is FDA-cleared to assess MRD in patients with CLL, MM, or B-ALL. For imp. info, incl. sample types & test limitations https://t.co/FihIM4XpIK https://t.co/PXKp2DWbk4

Meet Tony! He’s a Value Access & Strategy Director who finds immense joy working with the talented, diverse people at Adaptive. Fun fact: he once worked as an elephant and rhino monitor at the iSimangaliso World Heritage Site in South Africa. #HumansofAdaptive

test Twitter Media - Meet Tony! He’s a Value Access & Strategy Director who finds immense joy working with the talented, diverse people at Adaptive. Fun fact: he once worked as an elephant and rhino monitor at the iSimangaliso World Heritage Site in South Africa. #HumansofAdaptive https://t.co/p7k65j9BIx

#WVIC attendees, don’t miss CMO @LanceBaldoMD’s presentation on the use of novel T-cell tests for the early detection of infectious diseases and cancer. More at rebrand.ly/301kusr/. For Research Use Only. Not for use in diagnostic procedures.

test Twitter Media - #WVIC attendees, don’t miss CMO @LanceBaldoMD’s presentation on the use of novel T-cell tests for the early detection of infectious diseases and cancer. More at https://t.co/wYUIWC1y0l.

For Research Use Only. Not for use in diagnostic procedures. https://t.co/OncFRqgXEk

Happy Thanksgiving from all of us at Adaptive! While this year has brought many challenges, we are thankful for our Adaptive team, partners and collaborators for their dedication to our patients.

test Twitter Media - Happy Thanksgiving from all of us at Adaptive! While this year has brought many challenges, we are thankful for our Adaptive team, partners and collaborators for their dedication to our patients. https://t.co/BevYWB9ol8

Join us at #WVIC on Nov. 30 for a panel discussion on T-cell receptors (TCRs) from discovery to therapeutics featuring Chief Business Development Officer @SBenzeno. More at rebrand.ly/33qtatl. For Research Use Only. Not for use in diagnostic procedures. @vaccinenation

test Twitter Media - Join us at #WVIC on Nov. 30 for a panel discussion on T-cell receptors (TCRs) from discovery to therapeutics featuring Chief Business Development Officer @SBenzeno. More at https://t.co/IZuQWQb4d4.

For Research Use Only. Not for use in diagnostic procedures.

@vaccinenation https://t.co/jy0PzycHb2

We’re proud to be named one of @FastCompany’s Next Big Things in Tech! It’s an honor to be chosen alongside @MSFTResearch and other game-changers for the first-ever #FCTechAwards. More: rebrand.ly/5nuk4qk.‌ @FastCoTech

test Twitter Media - We’re proud to be named one of @FastCompany’s Next Big Things in Tech! It’s an honor to be chosen alongside @MSFTResearch and other game-changers for the first-ever #FCTechAwards. More: https://t.co/HrAilZPmRr.‌
 
@FastCoTech https://t.co/jdgm05Emp5

Congrats to @RachelGittelman, senior manager of computational biology, on her selection as a 2021 @STATNews Wunderkind! rebrand.ly/eao7z5y

MRD testing receives updated Medicare coverage for certain blood cancer patients. More: rebrand.ly/77pv0d8 @clonoSEQ is FDA-cleared to measure MRD in CLL, MM and B-ALL. For important info incl. cleared sample types & test limitations: rb.gy/8tju9y

test Twitter Media - MRD testing receives updated Medicare coverage for certain blood cancer patients. More: https://t.co/ptKrKA7jn3

@clonoSEQ is FDA-cleared to measure MRD in CLL, MM and B-ALL. For important info incl. cleared sample types & test limitations: https://t.co/FihIM4XpIK https://t.co/A9g9FxeVFT

Today we honor and thank all veterans. Thank you for your service and sacrifice. #VeteransDay2021

test Twitter Media - Today we honor and thank all veterans. Thank you for your service and sacrifice. #VeteransDay2021 https://t.co/6Nl5Ka65CR

Congrats to @FStPierreMD, recipient of our Q3 immunoSEQ® Young Investigator Award! The grant will support her research into the T-cell response to COVID-19 vaccines in blood cancer patients: rebrand.ly/w2rcy7y Research Use Only. Not for use in diagnostic procedures

test Twitter Media - Congrats to @FStPierreMD, recipient of our Q3 immunoSEQ® Young Investigator Award! The grant will support her research into the T-cell response to COVID-19 vaccines in blood cancer patients: https://t.co/5ZlkDSOqEl
 
Research Use Only. Not for use in diagnostic procedures https://t.co/UTAN6rRi0q

We are putting the ✨A✨ in the Big Apple. Today is the grand opening of our new office in New York City, which will be a home base for our investor relations and business development groups.

test Twitter Media - We are putting the ✨A✨ in the Big Apple. Today is the grand opening of our new office in New York City, which will be a home base for our investor relations and business development groups. https://t.co/EEnSWejzIB

#SITC2021 attendees, join us for a @sitcancer symposium on using immunosequencing in cancer research and immunotherapy. Learn more at rebrand.ly/bzi5qjh. For Research Use Only. Not for use in diagnostic procedures. #OncologyTwitter @UCLAHealth @smithimmunology

test Twitter Media - #SITC2021 attendees, join us for a @sitcancer symposium on using immunosequencing in cancer research and immunotherapy. Learn more at https://t.co/Ivueu8sJl3.  
  
For Research Use Only. Not for use in diagnostic procedures.  
  
#OncologyTwitter @UCLAHealth @smithimmunology https://t.co/FHbzPN6W69

November is National Family Caregivers month, a time to elevate the voices of caregivers. Diane Kennedy shares her experience as a care partner in her husband’s #myeloma journey. rebrand.ly/657j68f

First participant dosed in a clinical trial of next-generation COVID-19 vaccine candidates, including a T-cell-based vaccine validated by epitopes selected using Adaptive’s immune medicine platform and mapping of the T cell response to SARS-CoV-2. More: rebrand.ly/br4fhrn

test Twitter Media - First participant dosed in a clinical trial of next-generation COVID-19 vaccine candidates, including a T-cell-based vaccine validated by epitopes selected using Adaptive’s immune medicine platform and mapping of the T cell response to SARS-CoV-2. More: https://t.co/CpBV9TbrPr https://t.co/ZSRKJpGITw

We’re proud to announce that we have been selected as one of @Inc’s 2021 Best-Led Companies! Learn more about the honor: rebrand.ly/4l4bcq5

test Twitter Media - We’re proud to announce that we have been selected as one of @Inc’s 2021 Best-Led Companies! Learn more about the honor: https://t.co/J62k57DleU https://t.co/IJeUuJKsNT

Meet Anya! She’s a Senior Clinical Lab Scientist who’s passionate about evening strolls with her cat Behemoth, learning how to sail, and global medical systems. We’re lucky to have her on Team Adaptive. #HumansofAdaptive

test Twitter Media - Meet Anya! She’s a Senior Clinical Lab Scientist who’s passionate about evening strolls with her cat Behemoth, learning how to sail, and global medical systems. We’re lucky to have her on Team Adaptive. #HumansofAdaptive https://t.co/BfopjzLKji

Join us on Nov. 10 for a @NatureCustom webcast, featuring Thomas Snyder (VP, Research) and Jabran Zahid (@MSFTResearch) on how immunosequencing can identify HLA type. Register at rebrand.ly/c9nmjys. For Research Use Only. Not for use in diagnostic procedures.

test Twitter Media - Join us on Nov. 10 for a @NatureCustom webcast, featuring Thomas Snyder (VP, Research) and Jabran Zahid (@MSFTResearch) on how immunosequencing can identify HLA type.  
 
Register at https://t.co/Hd0ie88zzm.  
 
For Research Use Only. Not for use in diagnostic procedures. https://t.co/FNiZQqFNEN

The #myeloma treatment landscape is constantly changing. We discussed the importance of #MRD testing with @AhlstromJenny, a multiple myeloma patient and founder of @myelomacrowd. bit.ly/3w3sg8y #mmsm #mmMRD

Posted in .

Dana Crawford

Professor of Population and Quantitative Health Sciences and Associate Director of the Cleveland Institute for Computational Biology, with interest in pharmacogenomics, electronic health records, and diverse populations. Also, an avid foodie!